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Abstract K-Synuclein is the major ¢lamentous constituent of
Lewy bodies found in Parkinson’s disease (PD). The amyloid
formation of K-synuclein was signi¢cantly facilitated by oxi-
dized glutathione (GSSG) as the lag period of the aggregation
kinetics was shortened by 2.5-fold from its absence. Reduced
glutathione (GSH), on the other hand, did not in£uence the
lag phase although it increased the ¢nal amyloid formation.
The GSSG stimulation was speci¢c for not only K-synuclein
but also its intactness. The preferred GSSG interaction of
K-synuclein to GSH was also demonstrated with dissociation
constants of 0.53 and 43.5 mM, respectively. It is suggested
that the oxidative stress favoring the GSSG generation from
GSH could result in the augmented amyloid formation of K-syn-
uclein, which ought to be related to the pathogenesis of PD.
2 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Oxidative stress has been implicated in various age-related
neurodegenerative disorders [1,2]. Parkinson’s disease (PD)
shows clinical manifestations of resting tremor, slowness of
initial movement, rigidity, and general postural instability.
The disease has been pathologically characterized by progres-
sive loss of the dopaminergic neurons in the substantia nigra
and the presence of eosinophilic intraneuronal inclusions
called Lewy bodies [3]. K-Synuclein has been considered to
be a pathological component of PD because not only it con-
stitutes the Lewy bodies as the major ¢lamentous component
but also two independent missense mutations in its gene have
been identi¢ed from a few pedigrees of familial PD [4^6]. The
resulting proteins contain either proline or threonine replacing
alanine residues at positions 30 and 53 (Ala30Pro and
Ala53Thr), respectively [5,6]. When the protein was overex-
pressed in mice and £ies, the animals exhibited several char-
acteristics reminiscent of human PD including protein depo-
sition in the brain, dopaminergic neuronal loss, and de¢cits in
motor activity [7,8]. Although physiological function remains
elusive, the protein has been intensively examined with respect
to the amyloid formation and its implication in the patho-
genesis of PD [9,10].
There have been several reports indicating that oxidative
insults have in£uenced K-synuclein to be more aggregative.
Metals such as copper and iron gave rise to sodium dodecyl
sulfate (SDS)-resistant oligomers and/or aggregates of the
protein in the presence of hydrogen peroxide [11,12]. Nitra-
tion of K-synuclein also caused protein self-oligomerization
via o,oP-dityrosine crosslink formation [13]. Oxidative stress
has emerged from imbalance between generation of reactive
oxygen species (ROS) and antioxidative defense mechanism
[1,14]. Brain is especially susceptible to ROS because not
only the tissue consumes a large proportion of oxygen taken
into the body but also it contains higher amounts of mem-
brane lipids with polyunsaturated fatty acyl chains and tran-
sition metals including iron (and copper) which could be in-
volved in generation of hydroxyl radical in the presence of
hydrogen peroxide [1,14]. In addition, the nervous system is
poor at eliminating ROS because of its reduced catalase ac-
tivity with moderate amounts of superoxide dismutase and
glutathione peroxidase [14^16]. In PD, the oxidative stress
might be more serious because hydrogen peroxide level is
suggested to be increased with the augmented breakdown of
dopamine by monoamine oxidase [16,17], whereas the amount
of reduced glutathione (GSH), one of a few low molecular
weight antioxidants synthesized by the cell, has been substan-
tially decreased by 40% from 0.75 to 0.45 Wmol/g wet weight
of the a¡ected substantia nigra [18]. Intriguingly, however,
oxidized form of glutathione (GSSG) was insigni¢cantly in-
creased from 0.0024 to 0.0031 Wmol/g wet weight [18]. In this
report, we have examined direct molecular interaction be-
tween K-synuclein and GSH/GSSG in order to assess the re-
lationship between oxidative stress and abnormal protein ag-
gregation leading to the eventual amyloid formation.
2. Materials and methods
2.1. Materials
Reduced and oxidized glutathiones were purchased from Sigma.
Thio£avin-T, 5,5P-dithiobis-2-nitrobenzoic acid (DTNB), GSH-Seph-
arose, epoxy-activated Sepharose, thrombin, and endoproteinase Asp-
N were also obtained from Sigma. Carbon-coated copper grid and
centrifugal ¢lter (Ultra¢lter0-MC) were provided by Ted Pella Inc.
and Millipore, respectively. Uranyl acetate was from Electron Micro-
scope Science.
2.2. Preparation of the synucleins
Overexpressed recombinant K- and L-synucleins in Escherichia coli
were puri¢ed according to the procedures described previously [19,20].
The C-terminally truncated K-syn(1^97) was prepared with endopro-
teinase Asp-N treatment as described elsewhere [21]. The N-terminally
truncated K-syn(61^140) was overexpressed as a glutathione-S-trans-
ferase fusion protein. The recombinant protein was puri¢ed with glu-
tathione-Sepharose chromatography using 10 mM glutathione in 50
mM Tris^Cl, pH 7.5, as the elution bu¡er. Following thrombin di-
gestion (10 units/mg protein) for 4 h at 24‡C, K-syn(61^140) was
subjected to Q-Sepharose anion-exchange chromatography under a
linear gradient between 0 and 1 M NaCl in 20 mM Tris^Cl, pH
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7.5. The puri¢ed protein was dialyzed against 20 mM MES, pH 6.5,
and kept at 1.2 mg/ml in 330‡C.
2.3. Analysis of protein aggregation
Protein aggregations of K- and L-synucleins in the presence and
absence of 2 mM each of GSH and GSSG were examined with tur-
bidity by observing absorbance at 405 nm. Following ultracentrifuga-
tion at 100 000Ug for 10 min to remove any protein clumps which
could act as a nucleation center during the aggregation, either K-syn-
uclein (100 WM) or L-synuclein (131 WM) was mixed with the gluta-
thiones in 20 mM MES, pH 6.5, to a ¢nal volume of 1 ml and incu-
bated at room temperature with continuous shaking. Amyloid
formation of the protein aggregates was evaluated with thio£avin-T
binding £uorescence [22]. During the incubation, small aliquots (5 Wl)
were combined with 5 WM thio£avin-T in 50 mM glycine, pH 8.5, to a
¢nal volume of 300 Wl and the £uorescences were measured at 482 nm
with an excitation at 446 nm (LS55 Luminescence Spectrometer, Per-
kin-Elmer). Morphological appearances of the amyloids were also
examined with a transmission electron microscope (H7100, Hitachi).
Aliquots (5 Wl) of the aggregates were adsorbed onto carbon-coated
copper grid (300 mesh) and air-dried for 1 min. After negative stain-
ing with 2% uranyl acetate for another 1 min, the aggregates were
observed with the electron microscope.
For another set of experiments to localize the glutathione interac-
tion site(s), the synucleins such as K-synuclein, L-synuclein, K-syn(1^
97), and K-syn(61^140) were incubated at a ¢nal concentration of 90
WM with 2 mM GSH/GSSG in 20 mM MES, pH 6.5, for 96 h at room
temperature with continuous upside-down mixing (Rotamix SLRM1,
Seoulin Bioscience). Aliquots (20 Wl) of the 150 Wl ¢nal mixtures were
mixed with 5 WM thio£avin-T in 50 mM glycine, pH 8.5. Fluorescen-
ces of the mixtures (100 Wl) were measured at 485 nm with excitation
at 440 nm (FL500 Microplate Fluorescence Reader, Bio-Tek Instru-
ments).
2.4. Determination of Kd between K-synuclein and GSH/GSSG
Dissociation constants between K-synuclein and GSH/GSSG were
determined by employing immobilized K-synuclein on Sepharose gel
[20]. Derivatization of K-synuclein to the gel was carried out with pre-
swollen epoxy-activated Sepharose 6B in 0.1 M potassium phosphate,
pH 7.25. After packing the gel into a column, K-synuclein (4.3 mg/6
ml) was subjected to trace enrichment in the phosphate bu¡er by
using a peristaltic pump at a £ow rate of 0.25 ml/min for 85 h at
room temperature. The amount of immobilized protein was estimated
as 1 mg/ml of the gel. After blocking with 1 M ethanolamine, the
K-synuclein-Sepharose was kept in the phosphate bu¡er at 4‡C.
The K-synuclein-Sepharose corresponding to the ¢nal protein con-
centration of 5 WM was incubated with various concentrations of
GSH/GSSG in 20 mM MES, pH 6.5, for 30 min at 30‡C in a Ther-
momixer compact (Eppendorf) at 1000 rpm. Unbound GSH/GSSG
was separated from the bound ones with a centrifugal ¢lter with pore
size of 0.22 Wm (Ultra¢lter0-MC, Millipore) at 250Ug for 1 min.
After washing the gel with 200 Wl of the bu¡er, the bound glutathiones
were eluted with 1 M NaCl. Following 10 min of incubation, the
glutathiones were recovered with the centrifugation at 250Ug for
2 min. The amount of the bound GSH was quantitated with 0.4
mM DTNB by measuring absorbance of its reduced product,
5-thio-2-nitrobenzoate (TNB), at 405 nm using a microplate reader
(Elx 808, Bio-Tek Instruments) [23]. The recovered GSSG was enzy-
matically quanti¢ed with GSSG reductase in the presence of 0.4 mM
DTNB and 0.17 mM NADPH according to the procedure described
elsewhere [17,18]. Double reciprocal plots between total and bound
GSH/GSSG were drawn to obtain the dissociation constants.
3. Results and discussion
Amyloid formation of K-synuclein in the presence and ab-
sence of GSSG/GSH was evaluated with the thio£avin-T
binding £uorescence. The amyloid formation of K-synuclein
was signi¢cantly facilitated in the presence of 2 mM GSSG as
the lag period of the protein aggregation was shortened by
2.5-fold from its absence (Fig. 1A). While K-synuclein itself
started to form the aggregates after 125 h of prolonged lag
period, GSSG reduced the lag to around 50 h. On the other
hand, GSH did not a¡ect the lag although it increased the
¢nal £uorescence by 40% compared to the aggregation by
K-synuclein alone. The GSH e¡ect, however, was not ob-
served unless the amyloid of K-synuclein was started to
form by itself. GSSG/GSH alone did not give rise to the £uo-
rescence even after prolonged incubation (data not shown).
These data indicate that the GSSG interaction to K-synuclein
could provide a nucleation center for the amyloidosis of the
protein while the GSH interaction appeared to depend on the
prior aggregation of K-synuclein. Several independent obser-
Fig. 1. Protein aggregations of K- and L-synucleins in the presence
and absence of GSH/GSSG. K-Synuclein (100 WM) was incubated
with 2 mM each of GSH (R) and GSSG (F) and the aggregations
were analyzed with the thio£avin-T binding £uorescence (A) and
the turbidity (B). Aggregation of K-synuclein by itself (b) is shown
in each panel as a control. The aggregations of L-synuclein (131
WM) were also examined with the thio£avin-T binding £uorescence
(C) in the absence (b) and presence of GSH (R)/GSSG (F).
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vations consistently demonstrated that the GSH stimulation
has never proceeded to the amyloid formation of K-synuclein
by itself. When the aggregations were simultaneously eval-
uated with turbidities, GSSG exhibited the most dramatic
stimulation with prominent shortening of the lag period while
the aggregations obtained with and without GSH were slowly
increased to lesser extents (Fig. 1B). In the case of L-synuclein,
the thio£avin-T binding £uorescence was not observed at all
even in the presence and absence of GSSG/GSH, indicating
that the stimulatory GSSG e¡ect on the amyloid formation
was selective to K-synuclein (Fig. 1C).
Formation of ¢brous structures during the GSSG-induced
K-synuclein aggregation was morphologically analyzed with a
transmission electron microscope. After 125 h of incubation,
the aggregation obtained with GSSG clearly showed the ¢-
brous structures (Fig. 2C) while the aggregates generated in
the presence and absence of GSH did not form the amyloids
yet (Fig. 2A and B). The aggregates prepared with GSH
showed rather worm-like structures (Fig. 2B). All the ¢nal
aggregates, however, after the prolonged incubation of 200 h
with and without GSSG/GSH gave rise to the common
¢brous structures (Fig. 2D^F). It was, therefore, clear that
the GSSG stimulation of K-synuclein led to the authentic
amyloid formation.
The enhancing GSSG e¡ect on the amyloid formation of
K-synuclein was further examined with both N-terminally and
C-terminally truncated K-synucleins such as K-syn(61^140)
and K-syn(1^97), respectively, to localize the GSSG interac-
tion site(s). Intriguingly, it turned out that intactness of K-syn-
uclein was essential for the stimulatory e¡ect of GSSG. The
synucleins (90 WM) including K-synuclein, L-synuclein,
K-syn(1^97), and K-syn(61^140) were incubated with 2 mM
each of GSH/GSSG in 20 mM MES, pH 6.5, at room temper-
ature. Following 96 h of incubation, the amyloid formation
was estimated with the thio£avin-T binding £uorescence (Fig.
3). In this new set of experiments, the protein aggregation of
Fig. 2. Morphologies of the protein aggregates. The aggregates of K-synuclein prepared in the absence (A, D) and presence of 2 mM GSH
(B, E) or GSSG (C, F) were visualized with electron microscope. The protein aggregates were collected at two di¡erent time points of 125 h
(A, B, C) and 200 h (D, E, F) following the incubation. Scale bar represents 0.5 Wm.
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intact K-synuclein was stimulated by 3.8- and 2.5-fold in the
presence of GSSG and GSH, respectively. At the same time
point, however, L-synuclein again did not form the amyloid
even in the presence and absence of GSSG/GSH. For the
C-terminally truncated K-synuclein, both GSH and GSSG
did not stimulate the amyloid formation but rather inhibited
the protein aggregation of K-syn(1^97). In the case of N-ter-
minally truncated K-syn(61^140), GSSG did not in£uence the
aggregation process while GSH suppressed the aggregation by
75%. Although GSH has been shown to interact with all three
proteins of K-synuclein, K-syn(1^97), and K-syn(61^140), the
enhancing e¡ect on the £uorescence was observed only with
the intact protein whereas the aggregations of the other trun-
cated proteins were suppressed. For the GSSG interaction, the
N-terminal region of K-synuclein was necessary because the
aggregation of K-syn(61^140) was not a¡ected by the oxidized
glutathione. To exhibit the stimulatory e¡ect, however, the
acidic C-terminus seemed to be also required because the ag-
gregation of K-syn(1^97) was inhibited instead while that of
the intact molecule was dramatically stimulated by GSSG.
Requirement of the intactness for the stimulation could be
illustrated by either multiple ligand binding to K-synuclein
or alterations in residual structures of the protein, if any.
Based on these data, we could reach to a conclusion that
the stimulated amyloid formation by the oxidized glutathione
has been selective to not only K-synuclein but also its intact-
ness.
To understand physiological and/or pathological implica-
tions of the GSSG/GSH interaction of K-synuclein, actual
dissociation constants between the molecules were examined
by utilizing the immobilized K-synuclein. Dissociation con-
stant between K-synuclein and GSSG was estimated as 0.53
mM, which has exhibited much higher a⁄nity than GSH be-
cause the reduced glutathione gave rise to a Kd of 43.5 mM
(Fig. 4). This apparent 82-fold di¡erence in the dissociation
constants would make the GSSG interaction of K-synuclein
considered to be pathologically relevant while the GSH inter-
action might not be expected even under a physiological con-
dition. The low a⁄nity of GSH was also re£ected in the
aggregation kinetics of K-synuclein, where the GSH enhance-
ment on the amyloid formation was dependent upon the pre-
ceding aggregation of K-synuclein. Since the aggregation of
K-synuclein might not occur under normal condition in
vivo, the enhancing GSH e¡ect could be neglected from a
physiological point of view. The reduced glutathione, how-
ever, could participate in the amyloid formation under a con-
dition in which the K-synuclein aggregation becomes favor-
able. In the case of GSSG, its binding to K-synuclein with
the higher a⁄nity and resulting structural alterations would
make the protein more aggregative as observed in the aggre-
gation kinetics of the GSSG-stimulated amyloid formation
(Fig. 1A and B). Alternatively, GSSG could be also structur-
ally modi¢ed by the protein, which might in turn in£uence the
aggregation process as well. Since it was reported that GSSG
has transformed into a state of gel in the presence of organic
solvent [24], possible formation of any suprastructure among
GSSG molecules could facilitate K-synuclein to participate in
the aggregation process. Hence, mutual in£uences between
K-synuclein and GSSG could be responsible for the stimulated
amyloid formation.
Currently, the decreased level of GSH in PD has been in-
vestigated in terms of imposing oxidative stress to the degen-
erating dopaminergic neurons. In this study, we have exam-
ined direct molecular interaction between K-synuclein and
GSSG as a possible consequence of the reduced GSH level
and the augmented hydrogen peroxide generation via the en-
hanced dopamine breakdown in the disease. In fact, dopamine
breakdown has been shown to increase the GSSG level as the
GSH was decreased in rats [17]. It has been puzzling, how-
Fig. 3. E¡ects of GSH/GSSG on the amyloid formation of various
synucleins. The synucleins such as K-synuclein (I), L-synuclein (II),
K-syn(1^97) (III), and K-syn(61^140) (IV) were incubated with or
without 2 mM GSH/GSSG for 96 h at room temperature in 20
mM MES, pH 6.5, at a ¢nal concentration of 90 WM. The amounts
of amyloids were estimated with the thio£avin-T binding £uores-
cence. Each set of experiments consists of four columns representing
the £uorescences of background and protein aggregations obtained
in the absence and presence of GSH/GSSG as indicated on the bot-
tom of the panel.
Fig. 4. Double reciprocal plots to obtain Kd between K-synuclein
and GSH/GSSG. The immobilized K-synuclein (5 WM) was incuba-
ted with various concentrations of GSH (a) and GSSG (b). The
bound GSH/GSSG were separated from their free forms by using a
centrifugal ¢lter. Following quantitation, amounts of the bound and
total glutathiones (GSH/GSSG) were subjected to the double recip-
rocal plots.
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ever, that the GSSG level in the substantia nigra of PD brain
was insigni¢cantly increased while the GSH level was dramat-
ically decreased [18]. Nevertheless, our results could indicate
that the insigni¢cant increase of GSSG may have a patholog-
ical meaning more than expected because GSSG could a¡ect
K-synuclein more e¡ectively than GSH in vivo for the even-
tual production of amyloids. In any case, a conclusion ob-
tained from this study is that the oxidative stress favoring
the GSSG formation from GSH especially in PD could result
in the augmented amyloid formation of K-synuclein, which
ought to be related to pathogenesis of the disease.
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